Pharma-Bio Serv (OTCMKTS:PBSV) Issues Quarterly Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) posted its earnings results on Monday. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.35, reports. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%. The company had revenue of $2.47 million for the quarter, compared to analyst estimates of $2.70 million.

Pharma-Bio Serv Stock Performance

Shares of OTCMKTS PBSV opened at $0.43 on Wednesday. The stock has a market cap of $9.86 million, a PE ratio of -14.33 and a beta of 0.53. Pharma-Bio Serv has a fifty-two week low of $0.31 and a fifty-two week high of $0.90. The stock has a fifty day moving average of $0.55 and a 200-day moving average of $0.57.

Pharma-Bio Serv Announces Dividend

The company also recently announced a dividend, which will be paid on Thursday, March 20th. Shareholders of record on Friday, February 28th will be given a $0.075 dividend. The ex-dividend date of this dividend is Friday, February 28th. Pharma-Bio Serv’s dividend payout ratio is currently -250.00%.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.